Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
399.80
+4.00 (1.01%)
At close: Feb 10, 2026

STO:SOBI Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4783,8852,4092,6382,679
Depreciation & Amortization
3,4843,5893,0302,1901,924
Other Amortization
-1051058375
Asset Writedown & Restructuring Costs
6,612-15651467
Other Operating Activities
-1,501421325-329
Change in Accounts Receivable
--178-900-1,982452
Change in Inventory
--159286413-318
Change in Other Net Operating Assets
-508157-546763980
Operating Cash Flow
8,5657,3884,4704,5765,470
Operating Cash Flow Growth
15.93%65.28%-2.32%-16.34%11.04%
Capital Expenditures
-40-170-873-72-47
Sale of Property, Plant & Equipment
----3
Cash Acquisitions
-1,004--16,961--
Sale (Purchase) of Intangibles
-3,113-2,835-4,070-1,405-323
Investment in Securities
-41----
Other Investing Activities
-96-86---
Investing Cash Flow
-4,294-3,091-21,904-1,477-367
Long-Term Debt Issued
-14,22035,87613,67514,193
Long-Term Debt Repaid
-5,123-18,826-24,790-16,227-18,316
Net Debt Issued (Repaid)
-5,123-4,60611,086-2,552-4,123
Issuance of Common Stock
2454276,20689-
Other Financing Activities
555178-280-439-351
Financing Cash Flow
-4,323-4,00117,012-2,902-4,474
Foreign Exchange Rate Adjustments
-46-61-3511912
Miscellaneous Cash Flow Adjustments
-11---
Net Cash Flow
-99236-457316641
Free Cash Flow
8,5257,2183,5974,5045,423
Free Cash Flow Growth
18.11%100.67%-20.14%-16.95%11.01%
Free Cash Flow Margin
30.19%27.73%16.26%23.97%34.92%
Free Cash Flow Per Share
24.5220.8911.0415.0918.27
Cash Interest Paid
7261,091949309324
Cash Income Tax Paid
1,3273076416731,124
Levered Free Cash Flow
4,8221,529503.753,5354,485
Unlevered Free Cash Flow
5,3422,3031,1983,8214,747
Change in Working Capital
-508-180-1,160-8061,114
Source: S&P Global Market Intelligence. Standard template. Financial Sources.